DOSSIERS / CORDEN PHARMA INTERNATIONAL GMBH
← SearchExport PDF
Company dossier

Corden Pharma International GmbH

GERMANY · COMPANY
KYBE ID: DE-B8535_HRB701567 · B8535_HRB701567 · 1 sources
RISK SCORE31MEDIUM RISK
OverviewPeopleConnections 31Risk signals 2Sources

Key facts

active
Corden Pharma International GmbH
de
B8535_HRB701567
de
active
de
Otto-Hahn-Straße, 68723 Plankstadt.
de

Connections

31 links
Shared operator — likely the same administrator
Corden Pharma GmbHShared registered address · 4 share thisCorden Pharma Grundstücks GmbHShared registered address · 4 share thisCorden Pharma GmbHShared officer / director · 4 share thisSchmidt Invest GmbHShared officer / director · 4 share thisWP Mannheim GmbHShared officer / director · 4 share thisBoehringer Ingelheim International GmbHShared officer / director · 5 share thisMcKesson Europe AGShared officer / director · 5 share thisDr. Benzing Immobilien GmbHShared officer / director · 5 share thisBoehringer Ingelheim Pharma GmbH & Co. KGShared officer / director · 5 share thisSYNTHACON GmbHShared officer / director · 7 share thisLUMOCOAST LTDShared officer / director · 7 share thisWeylChem Höchst GmbHShared officer / director · 7 share thisimo Hüther AktiengesellschaftShared officer / director · 7 share thisWeylChem RM Holding GmbHShared officer / director · 7 share thisbeta Healthcare Verwaltungs GmbHShared officer / director · 8 share this

A shared address, domain or mail server is a lead, not a verdict — most often the same administrator (accountant / corporate-services provider), not a single group.

Showing 15 of 31 — full graph via /v1/entities/DE-B8535_HRB701567/network.

People with significant control

6 people
NameRoleFromSource
Bernd Krappofficer—Germany registry
Christian Doctor Ewersofficer—Germany registry
Karsten Doctor Benzingofficer—Germany registry
Kurt Doctor Keßelerofficer—Germany registry
Wolfgang Doctor Hilsofficer—Germany registry
Wolfgang Doctor Niedermaierofficer—Germany registry

Risk signals

2 matched
high

Business fragmentation

A director is shared across 10 companies — business-splitting (дробление) pattern

high

Phoenix predecessor

Shares a director with a failed, near-identically-named company (Corden Pharma GmbH · dissolved · name-sim 0.58) — phoenixing pattern (shed debts under a new company)

Risk journey — why 31?

2 signals
+16
Business fragmentation
+15
Phoenix predecessor
Composite risk score31/100